23andMe SPAC Presentation Deck

Adjusted EBITDA Reconciliation $ in M Net Income (+) Other Expense (Income) (+) Interest Expense (Income) Operating Income (+) Depreciation and Amortization (+) Stock-Based Compensation (+) Restructuring and Exit Costs Adjusted EBITDA FY19A Note: Fiscal year ended March 31. ¹ For the year ended March 31, 2020, restructuring includes $881,000 of stock-based compensation expense related to restructuring activities. ($184) 0 ($189) 10 37 ($141) FY20A ($251) (1) (6) ($258) 23 44 45 ($147) 1 23andMe Confidential and Proprietary Information 39

View entire presentation